Logo
Exxaro Resources Limited
Annual Financial Statements 2021
1Chapter
2Chapter
3Chapter
4Chapter
5Chapter
6Chapter
7Chapter
8Chapter
9Chapter
10Chapter
<Next
11Chapter
12Chapter
13Chapter
14Chapter
15Chapter
16Chapter
17Chapter
18Chapter
19Chapter
20Chapter
>Previous

CHAPTER 14:
People

  • 14.5DIRECTORS' AND PRESCRIBED OFFICERS' REMUNERATION
  • 14.5.1Remuneration policy

The remuneration and nomination committee has a defined mandate from the board of directors aimed at:

  • Ensuring that the chairman, directors and senior executives are fairly rewarded for their individual contributions to the group's overall performance
  • Ensuring that the remuneration strategies and packages, including the incentive schemes, are related to performance, are suitably competitive and give due regard to the interests of the shareholders and the financial and commercial health of the group
  • 14.5.2Summary of remuneration
NCOE/guaranteed remuneration
plus circumstantial
 
Short term
incentives
 
Long term
incentives
 
2021  Basic salary
R
 
Benefits and  
allowances1
R
  
Retirement  fund 
contributions 
R
 
Performance  
bonuses2
 
Gains on 
management 
share schemes 
R
 
Executive directors 
MDM Mgojo  6 947 131  291 500   662 456  4 079 336   22 856 637 
Dr. N Tsengwa6  5 366 990  211 657   449 202  2 840 928   7 241 197 
PA Koppeschaar  5 235 563  301 917   460 447  3 018 760   9 441 112 
Total executive directors' remuneration  17 549 684  805 074   1 572 105  9 939 024   39 538 946 
Prescribed officers 
V Balgobind  3 204 409  60 225   244 952  1 520 708   4 526 565 
AS De Angelis  2 986 668  60 442   216 365  1 414 066   4 214 814 
JG Meyer  3 624 697  329 399   361 866  1 870 110   4 862 538 
MI Mthenjane  3 667 531  93 883   306 820  1 762 768   5 324 051 
AT Ndoni7  415 740  30 118  81 726  
R Tatnall8  4 548 281  1 108 848  
SE van Loggerenberg9  292 895  11 180   18 900 
M Veti  3 664 113  348 495  1 738 666   5 308 035 
Total prescribed officers' remuneration  22 404 334  1 663 977   1 527 516  8 388 044   24 236 003 
Other 
2021  Exit payment 
paid 
R
 
Recognition3
R
  
Other4
R
  
Total 
remuneration 
R
 
Share-based 
payment 
expense5
R
  
Gains on 
management 
share schemes 
R
 
Total 
remuneration 
expense 
R
 
Executive directors 
MDM Mgojo  49 760   130 722   35 017 542  13 350 626  (22 856 637) 25 511 531 
Dr. N Tsengwa6  5 760   16 115 734  5 592 894  (7 241 197) 14 467 431 
PA Koppeschaar  7 760   18 465 559  6 131 435  (9 441 112) 15 155 822 
Total executive directors' remuneration  63 280   130 722   69 598 835  25 074 955  (39 538 946) 55 134 844 
Prescribed officers 
V Balgobind  5 760   16 336   9 578 955  2 617 682  (4 526 565) 7 670 072 
AS De Angelis  5 760   8 898 115  1 846 234  (4 214 814) 6 529 515 
JG Meyer  5 760   11 054 370  3 057 715  (4 862 538) 9 249 517 
MI Mthenjane  9 460   44 974   11 209 487  2 807 310  (5 324 051) 8 692 746 
AT Ndoni7  700 000   1 227 584  63 025  1 290 609 
R Tatnall8  5 657 129  5 657 129 
SE van Loggerenberg9  2 437 970  37 970   2 798 915  (850 361) 1 948 554 
M Veti  5 760   11 065 069  2 998 662  (5 308 035) 8 755 696 
Total prescribed officers' remuneration  2 437 970  32 500   799 280   61 489 624  12 540 267  (24 236 003) 49 793 888 
2021 Fees for
services
R
Fees for
services
rendered to
subsidiaries
R
Total
R
Non-executive directors
GJ Fraser-Moleketi 1 348 895 1 348 895
IN Malevu10 264 307 264 307
L Mbatha 667 102 61 184 728 286
VZ Mntambo 694 100 108 012 802 112
MJ Moffett11 306 340 188 100 494 440
LI Mophatlane 923 897 46 234 970 131
MLB Msimang12 438 671 438 671
EJ Myburgh 1 217 809 1 217 809
V Nkonyeni 991 677 236 500 1 228 177
CJ Nxumalo13 616 741 616 741
MG Qhena (chairman)14 1 267 377 1 267 377
J van Rooyen15 878 214 878 214
PCCH Snyders 1 012 324 1 012 324
Total non-executive directors' remuneration 10 627 454 640 030 11 267 484
1 Includes leave days purchased as well as travel and acting allowances.
2 All incentive schemes are performance related and were approved by the board of directors.
3 Includes long service awards, zero-fatality and LTIFR rewards.
4 Includes leave encashments and retention allowances.
5 Amount recognised for share-based payment expenses, in terms of IFRS 2, in respect of equity-settled share-based payment schemes for services rendered during the year. The employee will only be entitled to the options once all vesting conditions have been met.
6 Appointed to the board of directors on 16 March 2021.
7 Appointed on 1 November 2021.
8 Appointed on 10 March 2021, in terms of a fixed term employment contract.
9 Resigned on 18 February 2021.
10 Appointed on 22 June 2021.
11 Resigned on 11 May 2021.
12 Appointed on 15 March 2021.
13 Appointed on 1 February 2021.
14 Appointed on 19 April 2021.
15 Retired on 27 May 2021.

Retirement amounts relate to defined contribution retirement funds.

  NCOE/guaranteed remuneration
plus circumstantial
Short term
incentives
Long term
incentives
2020 Basic salary
R
Benefits and
allowances1
R
Retirement fund
contributions
R
Performance
bonuses2
R
Gains on
management
share schemes
R
Executive directors  
MDM Mgojo   6 627 730   266 787   639 299   3 415 080   13 751 712  
PA Koppeschaar   4 988 727   262 488   467 902   2 306 522   5 896 443  
Total executive directors' remuneration   11 616 457   529 275   1 107 201   5 721 602   19 648 155  
Prescribed officers  
V Balgobind   3 027 366   118 379   274 075   1 054 332   2 991 185  
AS De Angelis6   2 675 154   38 529   201 417   945 100  
AW Diedericks   3 572 940   140 460   344 328   1 352 442   4 128 484  
JG Meyer   3 523 117   325 578   356 873   1 401 716   4 129 899  
MI Mthenjane   3 570 108   91 481   302 587   1 321 260   3 521 955  
Dr. N Tsengwa   4 252 808   174 755   360 888   1 931 182   5 154 544  
SE van Loggerenberg7   2 045 234   78 345   139 721   595 928   1 474 560  
M Veti   3 557 153   9 132   343 687   1 303 196   3 431 710  
Total prescribed officers' remuneration   26 223 880   976 659   2 323 576   9 905 156   24 832 337  
  Other
2020 Recognition3
R  
Other4
R  
Total  
remuneration  
R  
Exit payment  
accrual (TVP)
R  
Share-based  
payment  
expense5
R  
Gains on  
management  
share schemes  
R  
Total  
remuneration  
expense  
R  
Executive directors  
MDM Mgojo   2 500   139 086   24 842 194   13 313 854   (13 751 712) 24 404 336  
PA Koppeschaar   2 500   13 924 582   6 074 786   (5 896 443) 14 102 925  
Total executive directors' remuneration   5 000   139 086   38 766 776   19 388 640   (19 648 155) 38 507 261  
Prescribed officers  
V Balgobind   2 500   11 838   7 479 675   2 695 734   (2 991 185) 7 184 224  
AS De Angelis6   2 500   3 862 700   1 679 588   5 542 288  
AW Diedericks   2 500   9 541 154   390 197   3 401 050   (4 128 484) 9 203 917  
JG Meyer   2 500   9 739 683   3 152 860   (4 129 899) 8 762 644  
MI Mthenjane   2 500   8 809 891   2 962 797   (3 521 955) 8 250 733  
Dr. N Tsengwa   2 500   11 876 677   4 637 600   (5 154 544) 11 359 733  
SE van Loggerenberg7   2 500   4 336 288   1 337 987   (1 474 560) 4 199 715  
M Veti   2 500   8 647 378   3 023 446   (3 431 710) 8 239 114  
Total prescribed officers' remuneration   20 000   11 838   64 293 446   390 197   22 891 062   (24 832 337) 62 742 368  
2020 Fees for
services
R
Benefits and
allowances
R
Total
R
Non-executive directors
GJ Fraser-Moleketi 1 162 496 1 162 496
L Mbatha 582 337 582 337
VZ Mntambo 728 933 728 933
MJ Moffett 933 861 933 861
LI Mophatlane 819 174 819 174
EJ Myburgh 1 229 321 1 229 321
V Nkonyeni 959 545 2 059 961 604
J van Rooyen (chairman) 2 128 588 2 128 588
A Sing8 294 136 294 136
PCCH Snyders 879 159 1 067 880 226
Total non-executive directors' remuneration 9 717 550 3 126 9 720 676
1 Includes leave days purchased as well as travel and acting allowances.
2 All incentive schemes are performance related and were approved by the board of directors.
3 Includes long service awards, zero-fatality and LTIFR rewards.
4 Includes leave encashments.
5 Amount recognised for share-based payment expenses, in terms of IFRS 2, in respect of equity-settled share-based payment schemes for services rendered during the year. The employee will only be entitled to the options once all vesting conditions have been met.
6 Appointed on 1 April 2020.
7 Resigned on 18 February 2021.
8 Retired on 28 May 2020.

Retirement amounts relate to defined contribution retirement funds.

  • 14.5.3Interests in Exxaro shares

(i) Number of shares

2021 2020
Directors at 31 December Direct Indirect Direct Indirect1
Beneficial interests
PA Koppeschaar 63 781 11 415 63 091 11 701 
MDM Mgojo 112 496 4 705 162 332 385 5 478 581 
VZ Mntambo 4 448 839 4 448 839 
Dr N Tsengwa 78 710 6 491
1 2020 has been re-presented to include the DBP pledge shares which were inadvertently disclosed as non-beneficial indirect interests.

(ii) Percentages (direct and indirect)

Directors at 31 December 2021% 2020%
PA Koppeschaar 0.02 0.02
MDM Mgojo 1.38 1.62
VZ Mntambo 1.27 1.24
Dr N Tsengwa 0.02

There have been no changes in the directors' interests in Exxaro shares between the end of the financial year 2021 and the date on which the annual financial statements were approved.

  • 14.5.4Share options and restricted share awards

The following options and rights in shares in the company were exercised or are outstanding in favour of directors and prescribed officers of the company under the company's share option schemes:

Management share scheme – LTIP

2021 Rights  
held at  
31 December1
Number  
Exercisable
period
Proceeds if  
exercisable at  
31 December2
R   
Pre-tax gain if  
exercisable at  
31 December2
R   
Modification
during the
year
Number
Options
exercised
during the year
Number
Shares  
forfeited3
Number  
Sale price/
market
price
R
Pre-tax
gain
R
Date exercised
Executive directors
MDM Mgojo 01/04/2021 107 989 53 985   177.96 19 217 722 15/04/2021
01/04/2021 5 248 3 499 1 749   174.39 610 191 23/09/2021
115 569   01/04/2022 17 667 033   17 667 033   3 627
181 029   01/04/2023 27 673 903   27 673 903   5 682
106 300   01/04/2024 16 250 081   16 250 081  
402 898   61 591 017   61 591 017   14 557 111 488 55 734   19 827 913
Dr. N Tsengwa 01/04/2021 39 177 19 585   177.96 6 971 939 15/04/2021
01/04/2021 1 904 1 270 634   174.39 221 475 23/09/2021
42 320   01/04/2022 6 469 458   6 469 458   1 329
66 289   01/04/2023 10 133 599   10 133 599   2 081
80 115   01/04/2024 12 247 180   12 247 180  
188 724   28 850 237   28 850 237   5 314 40 447 20 219   7 193 414
PA Koppeschaar 01/04/2021 50 701 25 346   177.96 9 022 750 15/04/2021
01/04/2021 2 464 1 643 821   174.39 286 523 23/09/2021
54 310   01/04/2022 8 302 370   8 302 370   1 705
85 072   01/04/2023 13 004 957   13 004 957   2 670
49 954   01/04/2024 7 636 468   7 636 468  
189 336   28 943 795   28 943 795   6 839 52 344 26 167   9 309 273
Prescribed officers
V Balgobind 01/04/2021 21 434 10 714   177.96 3 814 395 15/04/2021
01/04/2021 1 042 695 347   174.39 121 201 23/09/2021
22 938   01/04/2022 3 506 532   3 506 532   720
35 930   01/04/2023 5 492 619   5 492 619   1 128
20 503   01/04/2024 3 134 294   3 134 294  
79 371   12 133 445   12 133 445   2 890 22 129 11 061   3 935 596
AS de Angelis 01/04/2021 9 954 4 976   177.96 1 771 414 15/04/2021
01/04/2021 13 000 1 084   177.96 2 313 480 15/04/2021
01/04/2021 457 422 35   174.39 73 593 23/09/2021
01/04/2021 484 323 161   174.39 56 328 23/09/2021
10 702   01/04/2022 1 636 015   1 636 015   336
33 410   01/04/2023 5 107 387   5 107 387   1 049
19 066   01/04/2024 2 914 619   2 914 619  
63 178   9 658 021   9 658 021   2 326 23 699 6 256   4 214 815
JG Meyer 01/04/2021 26 482 13 238   177.96 4 712 737 15/04/2021
01/04/2021 1 287 859 428   174.39 149 801 23/09/2021
28 209   01/04/2022 4 312 310   4 312 310   886
44 185   01/04/2023 6 754 561   6 754 561   1 387
25 214   01/04/2024 3 854 464   3 854 464  
97 608   14 921 335   14 921 335   3 560 27 341 13 666   4 862 538
MI Mthenjane 01/04/2021 25 318 12 657   177.96 4 505 591 15/04/2021
01/04/2021 1 231 821 410   174.39 143 174 23/09/2021
26 589   01/04/2022 4 064 660   4 064 660   835
41 649   01/04/2023 6 366 883   6 366 883   1 308
23 767   01/04/2024 3 633 261   3 633 261  
92 005   14 064 804   14 064 804   3 374 26 139 13 067   4 648 765
AT Ndoni 12 165   01/11/2024 1 859 664   1 859 664  
12 165   1 859 664   1 859 664  
M Veti 01/04/2021 24 972 12 483   177.96 4 444 017 15/04/2021
01/04/2021 1 214 810 404   174.39 141 256 23/09/2021
26 226   01/04/2022 4 009 169   4 009 169   824
41 080   01/04/2023 6 279 900   6 279 900   1 290
23 442   01/04/2024 3 583 579   3 583 579  
90 748   13 872 648   13 872 648   3 328 25 782 12 887   4 585 273
1 Option strike price is nil.
2 Based on a share price of R152.87 which prevailed on 31 December 2021.
3 Shares forfeited due to performance conditions not being fully met.
2020 Rights  
held at  
31 December1
Number  
Exercisable
period
Proceeds if  
exercisable at  
31 December2
R   
Pre-tax gain if  
exercisable at  
31 December2
R   
Options
exercised
during
the year
Number
Shares  
forfeited3
Number  
Sale price/
market
price
R
Pre-tax
gain
R
Date exercised
Executive directors
MDM Mgojo 01/04/2020 136 871 11 418   99.25 13 584 447 01/04/2020
161 974   01/04/2021 22 498 189   22 498 189  
111 942   01/04/2022 15 548 744   15 548 744  
175 347   01/04/2023 24 355 698   24 355 698  
449 263   62 402 631   62 402 631   136 871 11 418   13 584 447
PA Koppeschaar 01/04/2020 59 410 4 956   99.25 5 896 443 01/04/2020
76 047   01/04/2021 10 562 928   10 562 928  
52 605   01/04/2022 7 306 835   7 306 835  
82 402   01/04/2023 11 445 638   11 445 638  
211 054   29 315 401   29 315 401   59 410 4 956   5 896 443
Prescribed officers
V Balgobind 01/04/2020 26 744 2 230   99.25 2 654 342 01/04/2020
32 148   01/04/2021 4 465 357   4 465 357  
22 218   01/04/2022 3 086 080   3 086 080  
34 802   01/04/2023 4 833 998   4 833 998  
89 168   12 385 435   12 385 435   26 744 2 230   2 654 342
AS de Angelis 14 930   01/04/2021 2 073 777   2 073 777  
14 084   01/04/2021 1 956 268   1 956 268  
10 366   01/04/2022 1 439 837   1 439 837  
32 361   01/04/2023 4 494 943   4 494 943  
71 741   9 964 825   9 964 825  
AW Diedericks 01/04/2020 33 804 2 819   99.25 3 355 047 01/04/2020
38 687   01/04/2021 5 373 624   5 373 624  
26 362   01/04/2022 3 661 682   3 661 682  
41 293   01/04/2023 5 735 598   5 735 598  
106 342   14 770 904   14 770 904   33 804 2 819   3 355 047
JG Meyer 01/04/2020 33 804 2 819   99.25 3 355 047 01/04/2020
39 720   01/04/2021 5 517 108   5 517 108  
27 323   01/04/2022 3 795 165   3 795 165  
42 798   01/04/2023 5 944 642   5 944 642  
109 841   15 256 915   15 256 915   33 804 2 819   3 355 047
MI Mthenjane 01/04/2020 33 181 2 767   99.25 3 293 214 01/04/2020
37 975   01/04/2021 5 274 728   5 274 728  
25 754   01/04/2022 3 577 231   3 577 231  
40 341   01/04/2023 5 603 365   5 603 365  
104 070   14 455 324   14 455 324   33 181 2 767   3 293 214
Dr. N Tsengwa 01/04/2020 50 008 4 171   99.25 4 963 294 01/04/2020
58 762   01/04/2021 8 162 042   8 162 042  
40 991   01/04/2022 5 693 650   5 693 650  
64 208   01/04/2023 8 918 491   8 918 491  
163 961 22 774 183   22 774 183   50 008 4 171   4 963 294
SE van Loggerenberg3 01/04/2020 6 057 505   99.25 601 157 01/04/2020
01/10/2020 7 043 587   124.01 873 402 07/10/2020
16 187   01/04/2021 2 248 374   2 248 374  
11 146   01/04/2022 1 548 179   1 548 179  
17 458   01/04/2023 2 424 916   2 424 916  
44 791   6 221 469   6 221 469   13 100 1 092   1 474 559
M Veti 01/04/2020 32 726 2 730   99.25 3 248 056 01/04/2020
37 455   01/04/2021 5 202 500   5 202 500  
25 402   01/04/2022 3 528 338   3 528 338  
39 790   01/04/2023 5 526 831   5 526 831  
102 647   14 257 669   14 257 669   32 726 2 730   3 248 056
1 Option strike price is nil.
2 Based on a share price of R138.90 which prevailed on 31 December 2020.
3 Shares forfeited due to performance conditions not being fully met.
4 Resigned on 18 February 2021.

Management share scheme – DBP

2021 Rights held at  
31 December1
Number  
Exercisable
period
Proceeds if  
exercisable at  
31 December2
R   
Pre-tax gain if  
exercisable at  
31 December2
R   
Modification
during the
year
Number
Options
exercised
during the
year
Number
Sale price/
market price
R
Pre-tax
gain
R
Date exercised
Executive directors
MDM Mgojo 09/03/2021 4 372 177.96 778 041 13/04/2021
09/03/2021 142 142 174.39 24 763 23/09/2021
31/03/2021 11 139 177.96 1 982 296 13/04/2021
31/03/2021 361 361 174.39 62 955 23/09/2021
31/08/2021 33 1 036 174.39 180 668 01/10/2021
1 460   15/03/2022 223 190   223 190   46
8 618   31/03/2022 1 317 434   1 317 434   271
13 122   31/03/2023 2 005 960   2 005 960   412
1 319   31/08/2023 201 636   201 636   42
867   19/03/2024 132 538   132 538  
9 070   31/03/2024 1 386 531   1 386 531  
988   21/09/2024 151 036   151 036  
35 444   5 418 325   5 418 325   1 307 17 050 3 028 723
Dr. N Tsengwa 31/08/2021 9 274 174.39 47 783 01/10/2021
536   15/03/2022 81 938   81 938   17
2 436   31/03/2022 372 391   372 391   77
432   31/08/2023 66 040   66 040   14
589   19/03/2024 90 040   90 040  
2 770   31/03/2024 423 450   423 450  
6 763   1 033 859 1 033 859   117 274 47 783
PA Koppeschaar 31/08/2021 24 756 174.39 131 839 27/09/2021
5 543   31/03/2022 847 358   847 358   174
4 778   31/03/2023 730 413   730 413   150
1 004   31/08/2023 153 481   153 481   32
750   21/09/2024 114 653   114 653  
12 075   1 845 905   1 845 905   380 756 131 839
Prescribed officers
V Balgobind 09/03/2021 1 089 177.96 193 798 16/04/2021
09/03/2021 36 36 174.39 6 278 23/09/2021
31/03/2021 1 880 177.96 334 565 15/04/2021
31/03/2021 61 61 174.39 10 638 23/09/2021
31/08/2021 9 262 174.39 45 690 01/10/2021
363   15/03/2022 55 492   55 492   12
2 623   31/03/2022 400 978   400 978   83
2 241   31/03/2023 342 582   342 582   71
244   21/09/2024 37 300   37 300  
5 471   836 352   836 352   272 3 328 590 969
AS de Angelis 1 092   31/03/2023 166 934   166 934   35
466   31/08/2023 71 237   71 237   15
202   19/03/2024 30 880   30 880  
1 269   31/03/2024 193 992   193 992  
227   21/09/2024 34 701   34 701  
3 256   497 744   497 744   50
JG Meyer 4 942   31/03/2023 755 484   755 484   156
301   21/09/2024 46 014   46 014  
5 243   801 498   801 498   156
MI Mthenjane 09/03/2021 1 346 177.96 239 534 13/04/2021
09/03/2021 44 44 174.39 7 673 23/09/2021
31/03/2021 2 331 177.96 414 825 13/04/2021
31/03/2021 76 76 174.39 13 254 23/09/2021
120 3 797 675 286
M Veti 09/03/2021 1 326 177.96 235 975 13/04/2021
09/03/2021 43 43 174.39 7 499 23/09/2021
31/03/2021 2 314 177.96 411 799 13/04/2021
31/03/2021 75 75 174.39 13 079 23/09/2021
31/08/2021 10 312 174.39 54 410 01/10/2021
433   15/03/2022 66 193   66 193   14
1 730   31/03/2022 264 465   264 465   55
682   31/08/2023 104 257   104 257   22
449   19/03/2024 68 639   68 639  
3 180   31/03/2024 486 127   486 127  
278   21/09/2024 42 498   42 498  
6 752   1 032 179   1 032 179   219 4 070 722 762
1 Option strike price is nil.
2 Based on a share price of R152.87 which prevailed on 31 December 2021.
2020 Rights held at  
31 December1
Number  
Exercisable
period
Proceeds if  
exercisable at  
31 December2
R   
Pre-tax gain if  
exercisable at  
31 December2
R   
Options
exercised
during the year
Number
Sale price/
market price
R
Pre-tax
gain
R
Date exercised
Executive directors
MDM Mgojo 31/08/2020 1 209 138.35 167 265 01/09/2020
4 372   09/03/2021 607 271   607 271  
11 139   31/03/2021 1 547 207   1 547 207  
1 003   31/08/2021 139 317   139 317  
1 414   15/03/2022 196 405   196 405  
8 347   31/03/2022 1 159 398   1 159 398  
12 710   31/03/2023 1 765 419   1 765 419  
1 277   31/08/2023 177 375   177 375  
40 262   5 592 392   5 592 392   1 209 167 265
PA Koppeschaar 732   31/08/2021 101 675   101 675  
5 369   31/03/2022 745 754   745 754  
4 628   31/03/2023 642 829   642 829  
972   31/03/2023 135 011   135 011  
11 701   1 625 269   1 625 269  
Prescribed officers
V Balgobind 09/03/2020 1 054 104.33 109 964 24/03/2020
31/03/2020 1 891 97.81 184 959 03/04/2020
31/08/2020 303 138.35 41 920 08/09/2020
1 089   09/03/2021 151 262   151 262  
1 880   31/03/2021 261 132   261 132  
253   31/08/2021 35 142   35 142  
351   15/03/2022 48 754   48 754  
2 540   31/03/2022 352 806   352 806  
2 170   31/03/2023 301 413   301 413  
8 283   1 150 509   1 150 509   3 248 336 843
AS de Angelis 1 057   31/03/2023 146 817   146 817  
451   31/08/2023 62 644   62 644  
1 508   209 461   209 461  
AW Diedericks 09/03/2020 2 406 104.33 251 018 18/03/2020
31/03/2020 4 368 97.81 427 234 01/04/2020
31/08/2020 688 138.35 95 185 31/08/2020
2 484   09/03/2021 345 028   345 028  
4 287   31/03/2021 595 464   595 464  
557   31/08/2021 77 367   77 367  
773   15/03/2022 107 370   107 370  
3 098   31/03/2022 430 312   430 312  
4 641   31/03/2023 644 635   644 635  
690   31/08/2023 95 841   95 841  
16 530   2 296 017   2 296 017   7 462 773 437
JG Meyer 09/03/2020 2 413 104.33 251 748 16/03/2020
31/03/2020 4 375 97.81 427 919 01/04/2020
31/08/2020 688 138.35 95 185 02/09/2020
4 786   31/03/2023 664 775   664 775  
4 786   664 775   664 775   7 476 774 852
MI Mthenjane 09/03/2020 1 304 104.33 136 046 24/03/2020
31/08/2020 670 138.35 92 695 08/09/2020
1 346   09/03/2021 186 959   186 959  
2 331   31/03/2021 323 776   323 776  
3 677   510 735   510 735   1 974 228 741
Dr. N Tsengwa 09/03/2020 1 308 104.33 136 464 18/03/2020
31/08/2020 396 138.35 54 787 09/09/2020
265   31/08/2021 36 809   36 809  
519   15/03/2022 72 089   72 089  
2 359   31/03/2022 327 665   327 665  
418   31/08/2023 58 060   58 060  
3 561   494 623   494 623   1 704 191 251
M Veti 09/03/2020 1 271 104.33 132 603 23/03/2020
31/08/2020 369 138.35 51 051 07/09/2020
1 326   09/03/2021 184 181   184 181  
2 314   31/03/2021 321 415   321 415  
302   31/08/2021 41 948   41 948  
419   15/03/2022 58 199   58 199  
1 675   31/03/2022 232 658   232 658  
660   31/08/2023 91 674   91 674  
6 696   930 075   930 075   1 640 183 654
1 Option strike price is nil.
2 Based on a share price of R138.90 which prevailed on 31 December 2020.
Report SelectorReport Index
X

Generate your own report

You can create your own custom PDF version of the report.

Select your areas of interest from the list below and submit your selection to create a PDF ready for you to download.

CHAPTER 1: THE YEAR IN BRIEF
Add section
The year in brief

CHAPTER 2: REPORTS
Add section
2.1 Responsibility statement on internal financial controls
2.2 Certificate by the group company secretary
2.3 Report of the directors
2.4 Audit committee report
2.5 Independent auditor's report

CHAPTER 3: SEGMENTAL REPORTING
Add section
3.1 Accounting policy relating to segmental reporting
3.2 Significant judgements and assumptions made by management in applying the related accounting policy
3.3 Reportable segments
3.4 Geographic location of segment assets

CHAPTER 4: FINANCIAL STATEMENTS
Add section
4.1.1 Group financial statements of comprehensive income
4.1.2 Group financial statements of financial position
4.1.3 Group financial statements of changes in equity
4.1.4 Group financial statements of cash flows
4.2.1 Company financial statement of comprehensive income
4.2.2 Company financial statement of financial position
4.2.3 Company financial statement of changes in equity
4.2.4 Company financial statement of cash flows

CHAPTER 5: EARNINGS
Add section
5.1 Accounting policy relating to earnings
5.2 Attributable earnings per share
5.3 Reconciliation of headline earnings
5.4 Headline earnings per share
5.5 Dividend distributions
5.6 Notes to the statements of cash flows relating to earnings

CHAPTER 6: OPERATIONAL PERFORMANCE AND WORKING CAPITAL
Add section
6.1 Operational performance
6.2 Working capital
6.3 Notes to the statements of cash flows relating to operational performance and working capital

CHAPTER 7: TAXATION
Add section
7.1 Accounting policies relating to taxation
7.2 Significant judgements and assumptions made by management in applying the related accounting policies
7.3 Income tax (expense)/benefit
7.4 Reconciliation of tax rates
7.5 Deferred tax
7.6 Notes to the statements of cash flows relating to taxation
7.7 Tax effect of other comprehensive income

CHAPTER 8: BUSINESS ENVIRONMENT AND PORTFOLIO CHANGES
Add section
8.1 Accounting policies relating to business environment and portfolio changes
8.2 Significant judgements and assumptions made by management in applying the related accounting policies
8.3 Divestment of non-core assets
8.4 Impairment charges of non-current assets
8.5 Non-current assets and liabilities held-for-sale

CHAPTER 9: ASSOCIATES AND JOINT ARRANGEMENTS
Add section
9.1 Accounting policies relating to investments in associates and joint arrangements
9.2 Significant judgements and assumptions made by management in applying the related accounting policies
9.3 Income from investments in associates and joint ventures
9.4 Investments in associates and joint arrangements
9.5 Movement analysis of investments in associates and joint ventures
9.6 Summarised financial information of associates and joint ventures
9.7 Reconciliation of carrying amounts of investments in associates and joint ventures

CHAPTER 10: ASSETS
Add section
10.1 Property, plant and equipment
10.2 Intangible assets
10.3 Financial assets
10.4 Other assets

CHAPTER 11: LEASES
Add section
11.1 Accounting policies relating to leases
11.2 Judgements and assumptions made by management in applying the related accounting policies
11.3 Right-of-use assets
11.4 Lease liabilities

CHAPTER 12: FUNDING
Add section
12.1 Debt
12.2 Equity

CHAPTER 13: PROVISIONS AND CONTINGENCIES
Add section
13.1 Accounting policies relating to provisions and contingencies
13.2 Significant judgements and assumptions made by management in applying the related accounting policies
13.3 Provisions
13.4 Contingent liabilities

CHAPTER 14: PEOPLE
Add section
14.1 Accounting policies relating to employee benefits
14.2 Significant judgements and assumptions made by management in applying the related accounting policies
14.3 Employee benefits
14.4 Retirement employee obligations
14.5 Directors' and prescribed officers' remuneration

CHAPTER 15: RELATED PARTIES
Add section
15.1 Related-party transactions

CHAPTER 16: FINANCIAL INSTRUMENTS
Add section
16.1 Accounting policies relating to financial instruments
16.2 Judgements and assumptions made by management in applying the related accounting policies
16.3 Financial instruments

CHAPTER 17: SUBSIDIARIES
Add section
17.1 Accounting policies relating to subsidiaries
17.2 Significant judgements and assumptions made by management in applying the related accounting policies
17.3 Transactions with subsidiaries
17.4 Summary of investments in subsidiaries
17.5 Summary of indebtedness by/(to) subsidiaries
17.6 Detailed analysis of investments in subsidiaries
17.7 Non-controlling interests

CHAPTER 18: COMPLIANCE
Add section
18.1 Basis of preparation
18.2 Adoption of new, amended and revised standards and interpretations
18.3 Events after the reporting period

CHAPTER 19: CHANGES TO COMPARATIVE INFORMATION
Add section
19.1 Re-presentation of group comparative information
19.2 Restatement of company comparative information

CHAPTER 20: ANNEXURES
Add section
Annexure 1 Shareholder analysis
Annexure 2 Definitions
Annexure 3 Administration
Annexure 4 Shareholders' diary

ACRONYMS
Add section
Acronyms